• Latest Posts

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

Louvain-la-Neuve: A Belgian temple for success in cell therapy

Biotechs outperformed in the top 40 European Tech Companies

Cardio3 will launch an IPO in the United States